Your browser doesn't support javascript.
loading
[A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].
Liu, Xuesong; Song, Yuanlin; Guan, Weijie; Qiu, Haibo; Du, Bin; Li, Yimin; Liu, Yan; Shang, Hongcai; Zhong, Nanshan; Coronavirus Disease Emergency Project Research Collaboration, Group.
Afiliação
  • Liu X; State Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
  • Song Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China.
  • Guan W; State Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
  • Qiu H; Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, Jiangsu, China.
  • Du B; Medical Intensive Care Unit, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Li Y; State Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
  • Liu Y; Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing University of Chinese Medicine, Beijing 100070, China. Corresponding author: Zhong Nanshan, Email: nanshan@vip.163.com; Shang Hongcai, Email: shanghongcai@126.com.
  • Shang H; Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing University of Chinese Medicine, Beijing 100070, China. Corresponding author: Zhong Nanshan, Email: nanshan@vip.163.com; Shang Hongcai, Email: shanghongcai@126.com.
  • Zhong N; State Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue ; 33(7): 774-778, 2021 Jul.
Article em Zh | MEDLINE | ID: mdl-34412743
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Medicamentos de Ervas Chinesas / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: Zh Revista: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Medicamentos de Ervas Chinesas / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: Zh Revista: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China